Resmed Inc at Citi Healthcare Conference (Virtual) Transcript
Good afternoon, everybody, or good morning or good evening, depending on where you are. My name is Joanne Wuensch. I'm the U.S. medical technology analyst. Very pleased to have with us today CEO, Mick Farrell from ResMed. As many of you know, ResMed is covered by our Australian analyst John Deakin-Bell. Today, I'm the moderator. So let's just get started.
Questions & Answers
Mick, the industry is dominated - commentary, at least - is dominated currently by the Philips device recall. In John's memory, this is about a 3.5 million units, which are recalled, and a key question to start off this discussion is how are the customers coping? And how are the physicians coping with this impact?
Yes. Well, I believe the latest data, Joanne, is -- John was right about 2 months ago. I think our competitor updated it to 5.2 million devices that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
